Macrolide Resistance in Streptococcus pneumoniae
MR Schroeder, DS Stephens - Frontiers in cellular and infection …, 2016 - frontiersin.org
Streptococcus pneumoniae is a common commensal and an opportunistic pathogen.
Suspected pneumococcal upper respiratory infections and pneumonia are often treated with …
Suspected pneumococcal upper respiratory infections and pneumonia are often treated with …
Streptococcus pneumoniae serotype 19A: worldwide epidemiology
R Isturiz, HL Sings, B Hilton, A Arguedas… - Expert review of …, 2017 - Taylor & Francis
Introduction: Streptococcus pneumoniae causes mucosal and invasive diseases with high
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …
An overview of macrolide resistance in streptococci: prevalence, mobile elements and dynamics
D Berbel, A González-Díaz, G López de Egea… - Microorganisms, 2022 - mdpi.com
Streptococcal infections are usually treated with beta-lactam antibiotics, but, in case of
allergic patients or reduced antibiotic susceptibility, macrolides and fluoroquinolones are the …
allergic patients or reduced antibiotic susceptibility, macrolides and fluoroquinolones are the …
Interim results of an ecological experiment—conjugate vaccination against the pneumococcus and serotype replacement
WP Hausdorff, WP Hanage - Human vaccines & …, 2016 - Taylor & Francis
Streptococcus pneumoniae has more than 95 serotypes, each of which presumably can
cause sepsis, meningitis, pneumonia, and acute otitis media. Pneumococcal conjugate …
cause sepsis, meningitis, pneumonia, and acute otitis media. Pneumococcal conjugate …
Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta …
A Bardach, S Ruvinsky, MC Palermo, T Alconada… - PLoS …, 2024 - journals.plos.org
Background Invasive pneumococcal diseases (IPD) are associated with high morbidity,
mortality, and health costs worldwide, particularly in Latin America and the Caribbean (LAC) …
mortality, and health costs worldwide, particularly in Latin America and the Caribbean (LAC) …
Antimicrobial Resistance Among Streptococcus pneumoniae
C Cillóniz, C Garcia-Vidal, A Ceccato… - Antimicrobial Resistance in …, 2018 - Springer
Antibiotic resistance in Streptococcus pneumoniae (pneumococcus), the main pathogen
responsible for community-acquired pneumonia (CAP), meningitis, bacteremia, and otitis …
responsible for community-acquired pneumonia (CAP), meningitis, bacteremia, and otitis …
[HTML][HTML] Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil
MCC Brandileone, SCG Almeida, R Minamisava… - Vaccine, 2018 - Elsevier
Abstract Background In March 2010, the 10-valent pneumococcal conjugate vaccine
(PCV10) was introduced into the routine immunization program in Brazil. We describe the …
(PCV10) was introduced into the routine immunization program in Brazil. We describe the …
Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent …
AP Cassiolato, SCG Almeida, AL Andrade… - PLoS …, 2018 - journals.plos.org
Background In 2010, a ten–valent pneumococcal conjugate vaccine (PCV10) was
introduced in the routine infant national immunization program in Brazil. Invasive …
introduced in the routine infant national immunization program in Brazil. Invasive …
Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru
BE Gonzales, EH Mercado… - Frontiers in Cellular …, 2022 - frontiersin.org
Streptococcus pneumoniae upper respiratory infections and pneumonia are often treated
with macrolides, but recently macrolide resistance is becoming an increasingly important …
with macrolides, but recently macrolide resistance is becoming an increasingly important …
Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: Nationwide surveillance from 2007 to 2019
MCC Brandileone, SCG Almeida, S Bokermann… - Vaccine, 2021 - Elsevier
Background Brazil introduced 10-valent pneumococcal conjugate vaccine (PCV10) into its
immunization program in 2010. We assessed antimicrobial susceptibility of Streptococcus …
immunization program in 2010. We assessed antimicrobial susceptibility of Streptococcus …